Hazard ratios for relapse and death for patients who received carboplatin treatment (a) and patients who did not receive carboplatin treatment (b) in the original INNSBRUCK set. (PDF 183 kb
Comparison of the predictive score of our HOTAIR DNA methylation signature (red) to those obtained f...
Predicting HOTAIR expression with the 67-CpG DNA methylation signature. A ROC analysis was used to o...
Expression analyses for the GRONINGEN set. Of the 175 samples from the GRONINGEN set, 114 samples ha...
Hazard ratios (HR) for death of patients who received carboplatin-based treatment in the GRONINGEN s...
Clinicopathological characteristics of ovarian cancer patients from the EUROPE set. (PDF 177 kb
Clinicopathological characteristics of ovarian cancer patients (INNSBRUCK set) for which HOTAIR expr...
Performance of the DNAme signature in the primary INNSBRUCK carboplatin-treated ovarian cancer set a...
Clinicopathological characteristics of ovarian cancer patients from TCGA set. (PDF 178 kb
Clinicopathological features of patients (GRONINGEN set) stratified according to HOTAIR expression. ...
Kaplan-Meier survival estimates for patients whose tumours expressed HOTAIR (a, c) and whose tumours...
Performance of the DNAme signature in the carboplatin-treated set from the ROCHESTER-MAYO set. (PDF ...
Boxplots of beta methylation values of the 67 CpGs (INNBSRUCK set) which demonstrate the largest dif...
Normalised beta-value DNAme data matrix that was used to identify the 67 HOTAIR -associated CpGs. Th...
Kaplan-Meier survival estimates in patients from the BERGEN set who received no chemotherapy (untrea...
Enrichment odds ratios (OR) with 95Â % confidence intervals for PCGTs according to different definit...
Comparison of the predictive score of our HOTAIR DNA methylation signature (red) to those obtained f...
Predicting HOTAIR expression with the 67-CpG DNA methylation signature. A ROC analysis was used to o...
Expression analyses for the GRONINGEN set. Of the 175 samples from the GRONINGEN set, 114 samples ha...
Hazard ratios (HR) for death of patients who received carboplatin-based treatment in the GRONINGEN s...
Clinicopathological characteristics of ovarian cancer patients from the EUROPE set. (PDF 177 kb
Clinicopathological characteristics of ovarian cancer patients (INNSBRUCK set) for which HOTAIR expr...
Performance of the DNAme signature in the primary INNSBRUCK carboplatin-treated ovarian cancer set a...
Clinicopathological characteristics of ovarian cancer patients from TCGA set. (PDF 178 kb
Clinicopathological features of patients (GRONINGEN set) stratified according to HOTAIR expression. ...
Kaplan-Meier survival estimates for patients whose tumours expressed HOTAIR (a, c) and whose tumours...
Performance of the DNAme signature in the carboplatin-treated set from the ROCHESTER-MAYO set. (PDF ...
Boxplots of beta methylation values of the 67 CpGs (INNBSRUCK set) which demonstrate the largest dif...
Normalised beta-value DNAme data matrix that was used to identify the 67 HOTAIR -associated CpGs. Th...
Kaplan-Meier survival estimates in patients from the BERGEN set who received no chemotherapy (untrea...
Enrichment odds ratios (OR) with 95Â % confidence intervals for PCGTs according to different definit...
Comparison of the predictive score of our HOTAIR DNA methylation signature (red) to those obtained f...
Predicting HOTAIR expression with the 67-CpG DNA methylation signature. A ROC analysis was used to o...
Expression analyses for the GRONINGEN set. Of the 175 samples from the GRONINGEN set, 114 samples ha...